Quantcast

Industry news that matters to you.  Learn more

Thirteen Proteomics Companies Form Proteomics Innovation Network

New England Peptide recently announced that it and twelve other product and service companies have started the global Proteomics Innovation Network to collaborate on unmet needs in drug discovery and personalized medicine.

The mission of the new proteomics network is to generate “from sample to discovery” solutions in all facets of proteomics, including expression, identification, characterization, interaction and function. Each member organization has complementary expertise, core technologies, and infrastructure to address critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring.

Computable Genomix Secures Investment for the Development of Genetic Biomarker Tests

Memphis-based Computable Genomix announced this week that it has secured an investment from venture capital firm Innova Memphis to pilot a novel process for developing genetic biomarker tests. Leveraging its next-generation computational discovery capability, the company is developing highly targeted genetic biomarker tests for clinical researchers.